...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: zenith trials

Could see Zenith Epigenetics get a similar SP  lift with similar news in their Breast cancer trial or an FDA fast track on any of their clinical trials currently being done . Would love to see it happen 

 

https://finance.yahoo.com/news/ambrx-shares-surge-encouraging-early-140448414.html

 

 

 

Share
New Message
Please login to post a reply